Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.760
-0.010 (-0.27%)
At close: Aug 28, 2026, 4:00 PM EDT
3.770
+0.010 (0.27%)
After-hours: Aug 28, 2026, 4:27 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $20.32 million as of August 28, 2026. Its market cap has increased by 5.77% in one year.
Market Cap
20.32M
Enterprise Value
914.68K
1-Year Change
5.77%
Ranking
Category
Stock Price
$3.76
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $20.32M, an increase of 88.35%. That is a compound annual growth rate of 45.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 20.32M | -2.60% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 22.84M |
| Allarity Therapeutics | 22.43M |
| Dyadic International | 22.38M |
| ABVC BioPharma | 21.52M |
| Longeveron | 21.42M |
| Cocrystal Pharma | 21.19M |
| Akari Therapeutics, | 20.83M |
| Niki BioSolutions | 20.28M |